Zylox-Tonbridge Medical Technology Company Description

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People’s Republic of China and internationally.

The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices.

It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products.

In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021.

Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People’s Republic of China.

Zylox-Tonbridge Medical Technology Co., Ltd.

Country	China
Founded	2012
Industry	Medical Devices
Sector	Healthcare
Employees	875
CEO	Zhong Zhao

Contact Details

Address: Zylox-Tonbridge Industrial Park Hangzhou China
Phone	86 571 8861 0082
Website	zyloxtb.com

Stock Details

Ticker Symbol	2190
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100004JD2
SIC Code	3841

Key Executives

Name	Position
Dr. Zhong Zhao Ph.D.	Founder, Chairman and Chief Executive Officer
Yang Xie	Senior Vice President of Sales and Marketing and Executive Director
Dr. Zheng Li	Senior Vice President, GM of Neurovascular Business and Executive Director
Quanwei Yuan	Chief Financial Officer and Joint Company Secretary
Sau In Kwan	Joint Company Secretary